CURIS, INC. Restricted Cash, Noncurrent
CURIS, INC. (CRIS) had Restricted Cash, Noncurrent of $0 as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashNoncurrent · last filed 2026-08-14
- 2026-06-30: Restricted Cash, Noncurrent $0.00.
- 2026-03-31: Restricted Cash, Noncurrent $544.00K.
- 2025-12-31: Restricted Cash, Noncurrent $544.00K.
- 2025-09-30: Restricted Cash, Noncurrent $544.00K.
| Period end | Restricted Cash, Noncurrent |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 |
| 2026-03-31 | $544.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $544.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $544.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $544.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $544.00K 10-Q · filed 2025-05-06 |
| 2024-12-31 | $544.00K 10-K · filed 2026-03-24 |
| 2024-09-30 | $544.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $544.00K 10-Q · filed 2024-08-01 |
| 2024-03-31 | $544.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $544.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $544.00K 10-Q · filed 2024-11-14 |
| 2023-06-30 | $635.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $635.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $635.00K 10-K · filed 2024-02-08 |
| 2022-09-30 | $635.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $635.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $726.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $726.00K 10-K · filed 2023-03-13 |
| 2021-09-30 | $726.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $816.00K 10-Q · filed 2021-08-03 |
| 2021-03-31 | $816.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $816.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $816.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $816.00K 10-Q · filed 2020-08-04 |
| 2020-03-31 | $816.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $816.00K 10-K · filed 2021-03-16 |
| 2018-12-31 | $153.00K 10-K · filed 2020-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |